Yih Lee

Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression

Mark S. Kramer, Andrew Winokur, Jeffrey E. Kelsey et al. · Neuropsychopharmacology · 2003 · 258 citations

Psychiatry, Functional Selectivity, Medicine +14

Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial

Clarissa E. Vergunst, Daniëlle M. Gerlag, Luba Lopatinskaya et al. · Arthritis & Rheumatism · 2008 · 232 citations

Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region

Jim Gilbert, Julie Lekstrom-Himes, Debra D. Donaldson et al. · The American Journal of Cardiology · 2011 · 175 citations

Inflammation, Ccr2 Blockade, Single Nucleotide Polymorphism +10

Phase I Trial of the Prostate-Specific Membrane Antigen–Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer

Matthew D. Galsky, Mario Eisenberger, S. Moore-Cooper et al. · Journal of Clinical Oncology · 2008 · 142 citations · Full text

Evaluation of Potential Inductive Effects of Aprepitant on Cytochrome P450 3A4 and 2C9 Activity

Craig R. Shadle, Yih Lee, Anup Majumdar et al. · The Journal of Clinical Pharmacology · 2004 · 127 citations · Full text

Healthy Subjects, Immunology, Receptor Antagonist +16